-
Something wrong with this record ?
Ultrasound guided ablative-laser assisted photodynamic therapy of basal cell carcinoma (US-aL-PDT)
R. Smucler, M. Kriz, J. Lippert, M. Vlk
Language English Country United States
Document type Comparative Study, Journal Article
PubMed
22316283
DOI
10.1089/pho.2011.3107
Knihovny.cz E-resources
- MeSH
- Carcinoma, Basal Cell pathology therapy ultrasonography MeSH
- Adult MeSH
- Esthetics MeSH
- Photochemotherapy methods MeSH
- Risk Assessment MeSH
- Immunohistochemistry MeSH
- Biopsy, Needle MeSH
- Cohort Studies MeSH
- Combined Modality Therapy MeSH
- Aminolevulinic Acid analogs & derivatives pharmacology MeSH
- Laser Therapy methods MeSH
- Middle Aged MeSH
- Humans MeSH
- Skin Neoplasms pathology therapy ultrasonography MeSH
- Follow-Up Studies MeSH
- Face MeSH
- Prospective Studies MeSH
- Aged, 80 and over MeSH
- Aged MeSH
- Treatment Outcome MeSH
- Check Tag
- Adult MeSH
- Middle Aged MeSH
- Humans MeSH
- Male MeSH
- Aged, 80 and over MeSH
- Aged MeSH
- Female MeSH
- Publication type
- Journal Article MeSH
- Comparative Study MeSH
OBJECTIVE: With proper noninvasive ultrasound measurement of tumor depth, case selection for laser pre-ablation followed by PDT is possible. This combination of methods provides a less invasive approach to the treatment of BCC. BACKGROUND DATA: Basal cell carcinoma (BCC) primarily affects the face, and, therefore, radical excision is problematic because of the possibility of poor aesthetic outcomes. Photodynamic therapy (PDT) offers an advantage in aesthetic outcomes, but topical PDT is only effective for tumors with a depth up to 2 mm. MATERIALS AND METHODS: Seventy-five histologically verified BCCs from 67 patients were selected and divided into three therapeutic groups based on the tumor depth, which was determined by 20 MHz skin ultrasound. The three groups were: A/<2 mm (PDT), B/ 2-3 mm (Er:YAG laser ablation+PDT), and C/>3 mm (diode laser ablation+PDT). The treatment consisted of laser ablation (or no ablation) followed by the application of methyl-aminolevulinate (MAL) and a 3-h treatment period using an occlusive bandage. Subsequently, illumination with 630 nm (MAL-PDT) was performed. MAL-PDT was repeated 1-3 weeks after the first treatment. A clinical evaluation was performed after 6 months. RESULTS: A 100% clearance rate (CR) in the group with the deepest tumors was observed. In addition, a 94.7% CR occurred in the group with tumors 2-3 mm in depth, and an 81.2% CR was observed in the group with superficial tumors. CONCLUSIONS: With proper ultrasound case selection and laser ablation before MAL-PDT, the depth of a BCC lesion is not a limiting factor for PDT, and aesthetic outcomes are very good. Therefore, ultrasound-guided ablative laser-assisted PDT of BCC can be the method of choice, particularly in aesthetically challenging cases.
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc12034747
- 003
- CZ-PrNML
- 005
- 20130428200505.0
- 007
- ta
- 008
- 121023s2012 xxu f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1089/pho.2011.3107 $2 doi
- 035 __
- $a (PubMed)22316283
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxu
- 100 1_
- $a Šmucler, Roman, $d 1969- $7 jn20000402855 $u Centre of Photonic Medicine, Charles University, Prague, Czech Republic. roman.smucler@lf1.cuni.cz
- 245 10
- $a Ultrasound guided ablative-laser assisted photodynamic therapy of basal cell carcinoma (US-aL-PDT) / $c R. Smucler, M. Kriz, J. Lippert, M. Vlk
- 520 9_
- $a OBJECTIVE: With proper noninvasive ultrasound measurement of tumor depth, case selection for laser pre-ablation followed by PDT is possible. This combination of methods provides a less invasive approach to the treatment of BCC. BACKGROUND DATA: Basal cell carcinoma (BCC) primarily affects the face, and, therefore, radical excision is problematic because of the possibility of poor aesthetic outcomes. Photodynamic therapy (PDT) offers an advantage in aesthetic outcomes, but topical PDT is only effective for tumors with a depth up to 2 mm. MATERIALS AND METHODS: Seventy-five histologically verified BCCs from 67 patients were selected and divided into three therapeutic groups based on the tumor depth, which was determined by 20 MHz skin ultrasound. The three groups were: A/<2 mm (PDT), B/ 2-3 mm (Er:YAG laser ablation+PDT), and C/>3 mm (diode laser ablation+PDT). The treatment consisted of laser ablation (or no ablation) followed by the application of methyl-aminolevulinate (MAL) and a 3-h treatment period using an occlusive bandage. Subsequently, illumination with 630 nm (MAL-PDT) was performed. MAL-PDT was repeated 1-3 weeks after the first treatment. A clinical evaluation was performed after 6 months. RESULTS: A 100% clearance rate (CR) in the group with the deepest tumors was observed. In addition, a 94.7% CR occurred in the group with tumors 2-3 mm in depth, and an 81.2% CR was observed in the group with superficial tumors. CONCLUSIONS: With proper ultrasound case selection and laser ablation before MAL-PDT, the depth of a BCC lesion is not a limiting factor for PDT, and aesthetic outcomes are very good. Therefore, ultrasound-guided ablative laser-assisted PDT of BCC can be the method of choice, particularly in aesthetically challenging cases.
- 650 _2
- $a dospělí $7 D000328
- 650 _2
- $a senioři $7 D000368
- 650 _2
- $a senioři nad 80 let $7 D000369
- 650 _2
- $a kyselina aminolevulová $x analogy a deriváty $x farmakologie $7 D000622
- 650 _2
- $a jehlová biopsie $7 D001707
- 650 _2
- $a bazocelulární karcinom $x patologie $x terapie $x ultrasonografie $7 D002280
- 650 _2
- $a kohortové studie $7 D015331
- 650 _2
- $a kombinovaná terapie $7 D003131
- 650 _2
- $a estetika $7 D004954
- 650 _2
- $a obličej $7 D005145
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a následné studie $7 D005500
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a imunohistochemie $7 D007150
- 650 _2
- $a laserová terapie $x metody $7 D053685
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a lidé středního věku $7 D008875
- 650 _2
- $a fotochemoterapie $x metody $7 D010778
- 650 _2
- $a prospektivní studie $7 D011446
- 650 _2
- $a hodnocení rizik $7 D018570
- 650 _2
- $a nádory kůže $x patologie $x terapie $x ultrasonografie $7 D012878
- 650 _2
- $a výsledek terapie $7 D016896
- 655 _2
- $a srovnávací studie $7 D003160
- 655 _2
- $a časopisecké články $7 D016428
- 700 1#
- $a Kříž, Martin. $7 _AN029105
- 700 1_
- $a Lippert, Jan, $d 1977- $7 xx0121771
- 700 1_
- $a Vlk, Marek $7 xx0107204
- 773 0_
- $w MED00181053 $t Photomedicine and laser surgery $x 1557-8550 $g Roč. 30, č. 4 (2012), s. 200-5
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/22316283 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a
- 990 __
- $a 20121023 $b ABA008
- 991 __
- $a 20130428200802 $b ABA008
- 999 __
- $a ok $b bmc $g 956757 $s 792244
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2012 $b 30 $c 4 $d 200-5 $i 1557-8550 $m Photomedicine and laser surgery $n Photomed Laser Surg $x MED00181053
- LZP __
- $a Pubmed-20121023